EpiCept Corporation Announces Pricing of Public Offering

Published: Mar 06, 2008

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today the pricing of a public offering of approximately 5.4 million shares of its common stock at $0.9225 per share and five-year warrants to purchase up to approximately 2.7 million shares of common stock at an exercise price of $0.86 per share, payable only on a net issuance basis in shares of its common stock. EpiCept will receive approximately $4.7 million in net proceeds from the offering. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM) acted as the exclusive placement agent for the offering. EpiCept intends to use the net proceeds for general corporate purposes.

Back to news